Effect of a Telephone-Based Lifestyle Intervention on Weight, Body Composition, and Metabolic Biomarkers in Rural Ohio: Results from a Randomized Pilot Study.
health disparities
metabolic biomarkers
obesity
remote
rural
weight loss
Journal
Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595
Informations de publication
Date de publication:
15 Sep 2023
15 Sep 2023
Historique:
received:
15
08
2023
revised:
08
09
2023
accepted:
12
09
2023
medline:
28
9
2023
pubmed:
28
9
2023
entrez:
28
9
2023
Statut:
epublish
Résumé
Rural residents experience higher rates of obesity, obesity-related chronic diseases, and poorer lifestyle. Promoting physical activity and healthy eating are critical for rural residents; however, lack of resources and access barriers limit the feasibility of in-person lifestyle interventions. There is a need to design and deliver remotely accessible lifestyle interventions in this population. This pilot study examined the effect of a telephone-based lifestyle intervention on weight, body composition, lipids, and inflammatory biomarkers among rural Ohio residents. Rural Ohio adults with overweight/obesity (n = 40) were 2:1 randomized to a 15-week telephone-based lifestyle intervention (n = 27) or control group (n = 13). The lifestyle intervention group received weekly telephone counseling sessions emphasizing healthy eating and increasing physical activity. The control group received educational brochures describing physical activity and dietary recommendations. Weight, body composition, fasting blood lipids, and inflammatory biomarkers were objectively measured at baseline and 15 weeks at local community centers (trial registration#: NCT05040152 at ClinicalTrial.gov). Linear mixed models were used to examine change over time by group. Participants were mostly female, with an average age of 49 years. Over the 15-week trial, the lifestyle intervention showed superior improvements in total cholesterol (∆ = -18.7 ± 7.8 mg/dL,
Identifiants
pubmed: 37764780
pii: nu15183998
doi: 10.3390/nu15183998
pmc: PMC10538144
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NCI NIH HHS
ID : F99 CA253745
Pays : United States
Organisme : NCI NIH HHS
ID : F99CA253745
Pays : United States
Références
Nature. 2019 May;569(7755):260-264
pubmed: 31068725
Am J Health Syst Pharm. 2002 Sep 15;59(18):1774-9
pubmed: 12298117
Lancet. 2014 Aug 30;384(9945):755-65
pubmed: 25129328
Eur J Clin Nutr. 2017 Nov;71(11):1329-1335
pubmed: 28876331
Cancer Prev Res (Phila). 2012 Nov;5(11):1260-72
pubmed: 23034147
Am J Health Promot. 2009 Mar-Apr;23(4):279-82
pubmed: 19288850
Cancer Res. 2012 May 1;72(9):2314-26
pubmed: 22549948
Obes Rev. 2019 May;20(5):713-724
pubmed: 30633845
Obes Rev. 2017 Jul;18(7):715-723
pubmed: 28489290
JAMA Netw Open. 2022 May 2;5(5):e2212246
pubmed: 35587350
Eat Behav. 2010 Jan;11(1):11-7
pubmed: 19962115
JAMA. 2021 Jan 26;325(4):363-372
pubmed: 33496775
Cancer Epidemiol Biomarkers Prev. 2018 Nov;27(11):1265-1274
pubmed: 28751476
N Engl J Med. 2016 Aug 25;375(8):794-8
pubmed: 27557308
Transl Behav Med. 2020 Dec 31;10(6):1554-1558
pubmed: 31228199
J Rural Health. 2012 Fall;28(4):392-7
pubmed: 23083085
J Cancer Epidemiol. 2013;2013:823849
pubmed: 23401687
JAMA Netw Open. 2020 Jun 1;3(6):e206764
pubmed: 32539150
Obesity (Silver Spring). 2011 Jun;19(6):1131-6
pubmed: 21183937
PLoS One. 2023 Mar 16;18(3):e0282719
pubmed: 36928626
J Clin Oncol. 2014 Nov 1;32(31):3568-74
pubmed: 25273035
Am J Prev Med. 2016 Nov;51(5):714-721
pubmed: 27593420
Cardiovasc Diabetol. 2019 Oct 1;18(1):127
pubmed: 31575375
Arch Intern Med. 2008 Nov 24;168(21):2347-54
pubmed: 19029500
Annu Rev Med. 2015;66:297-309
pubmed: 25587653
Cancer Epidemiol Biomarkers Prev. 2017 Jul;26(7):992-997
pubmed: 28600296
J Frailty Aging. 2022;11(2):151-155
pubmed: 35441191